about
A miR-19 regulon that controls NF-κB signalingMIF: Implications in the Pathoetiology of Systemic Lupus ErythematosusMacrophage migration inhibitory factor: a therapeutic target across inflammatory diseases.Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis.Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipperCritical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis.Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis.A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritisIdentification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin.Glucocorticoid-induced leucine zipper (GILZ) regulates testicular FOXO1 activity and spermatogonial stem cell (SSC) function.Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in miceIndependent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte traffickingDifferential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction.Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort.Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes.Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).Characteristics of azathioprine use and cessation in a longitudinal lupus cohort.Disseminated Enteroviral Infection Associated with Obinutuzumab.Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.Macrophage migration inhibitory factor and glucocorticoid sensitivity.Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26).Effects of glucocorticoids on inflammation and arthritis.Loss of autophagy enhances MIF/macrophage migration inhibitory factor release by macrophagesAssociation of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells.Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection.Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus.Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factor.Independent association of glucocorticoids with damage accrual in SLE.Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis.Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective.Asian ethnicity in systemic lupus erythematosus: an Australian perspective.The BAFF/APRIL system in SLE pathogenesis.Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.GILZ: Glitzing up our understanding of the glucocorticoid receptor in psychopathology.GILZ: a new link between the hypothalamic pituitary adrenal axis and rheumatoid arthritis?
P50
Q24602478-7779A0C2-D0E5-4F31-B2BD-4888C17F6489Q26776111-DC323301-E70A-42D2-8A49-48DAD9BD3027Q30364809-C8DC27D4-104F-4416-A555-EDB56DD12178Q33565136-7B682FD8-E56C-4C41-819B-5A489B5B5B22Q33976578-6B297B4C-258B-4097-AF9D-F80126D9D268Q34197622-3AF3489F-46CB-42C3-9660-EC4A0EC47E04Q34328155-C3467DA7-7732-449C-9D35-D3B9F9BE1479Q34571412-23232134-3FAE-40E7-8122-EB87D8AAAF4AQ34595260-95A03C0F-D5C8-4B9A-BD96-AB28F54AFCCFQ34630338-B70D8282-8A08-49E6-A874-739FE4ED0E0CQ34749922-4E1BBBFF-B67E-4AA9-BD98-A156E0F2F7E9Q34757879-C3538C9A-64B7-44BC-9285-591C1DA2837DQ35049835-1040FE49-C0CC-4B97-A1C0-9F5A21370091Q35163701-CFEBF83B-9429-4AFC-9B8B-90C3F16BAF20Q35216974-8F3E488B-63DA-4B88-9E8F-48E21837688FQ35399515-E257341E-5034-4571-B2AB-66FF30AB4DD7Q35609675-E6C34EF9-B23E-4C1A-BCC8-80A6A0AEAA81Q35803646-7D2F4F90-CF1C-4C8E-BB77-0B1A0DDBB009Q35992235-0E4D55F2-5CF6-4DCF-B0A7-8BBCE8F0CEC9Q35997459-6F1041E9-5234-4C31-8797-DB9C689431EEQ36188027-B4C05F91-B321-43F4-87FE-8D79FEDD3B88Q36315477-37040330-BF5A-4351-AA8B-58A292185AFBQ36390500-93F7B566-240F-4B74-B126-B0004083E96DQ36480668-746B46EE-3AE8-4D0D-889E-C9E125FA611AQ36603227-246E90E6-CB5B-4F2E-AE4D-D10C743BDE53Q36784052-C8C6D923-1F4D-4860-8007-6C2012668BC7Q37041545-C24B7179-5A98-41A2-B7BE-9D0DBB858AF1Q37121715-ABEFA448-2898-4987-B0C0-D48EE75612A6Q37209979-5DBD1BDB-99B1-4373-A6F4-A32B1BA42C4CQ37229642-1F1052B1-8B0D-4D2D-A2EC-AB87D14AC406Q37314750-71987118-F8FC-413F-9760-6FB0D2AC43F2Q37332678-3203AA23-0DE4-49E0-934B-51D5A58D23BAQ37464030-7ED0710A-A1F2-4D5B-96BD-70C6FAA385D5Q37873721-5CD820DD-48E3-4313-ACEF-FE90DD5C6258Q38062273-7BC94C17-47B1-47E1-B491-F7DE0F30C376Q38070903-536BF488-6BE7-406E-B60F-F20AA7F632DEQ38194895-909AAD12-884E-4C49-8A10-A032E02EE2EAQ38205079-8A7C5B49-1EA9-48DC-BE2C-B021E4DD3D43Q38220469-34E389AE-B02B-4ED7-B3AA-7414E0E4C3D6Q38232324-DBD0B76A-05AF-4084-B6E8-F5BC17A76420
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric F. Morand
@ast
Eric F. Morand
@en
Eric F. Morand
@es
Eric F. Morand
@nl
Eric F. Morand
@sl
type
label
Eric F. Morand
@ast
Eric F. Morand
@en
Eric F. Morand
@es
Eric F. Morand
@nl
Eric F. Morand
@sl
prefLabel
Eric F. Morand
@ast
Eric F. Morand
@en
Eric F. Morand
@es
Eric F. Morand
@nl
Eric F. Morand
@sl
P108
P1053
I-4718-2013
P106
P1153
7006125364
P21
P2798
P31
P3829
P496
0000-0002-9507-3338